Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Partnering

October 22, 2021 Events

PODD: Partnerships in Drug Delivery

PODD: Partnerships in Drug Delivery is offered as a hybrid program with a virtual option held on October 28-29, 2021.

Continue reading

October 20, 2021 Events / Pharma applications

AusBiotech 2021

AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.

Continue reading

October 8, 2021 Events / Pharma applications

BioJapan

BioJapan is Asia’s premier hyrid partnering event held on October 13–15, 2021 in Yokohama, Japan. This event is consituted by

Continue reading

February 26, 2021 Events

BIO-Europe Spring® Digital

BIO-Europe Spring® Digital for biopharmas will be held on March 22-25, 2021. This year’s digital event will include on-demand early

Continue reading

September 11, 2020 Events / Pharma applications

BIO Investor Forum – Digital Oct. 13-15, 2020

BIO Investor Forum Digital: The industry’s leading biopharma executives and BD professionals from public and venture-stage growth companies, and top

Continue reading

June 19, 2020 CD as API / CD derivatives / Pharma applications

Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition

Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed

Continue reading

March 11, 2019 Events / Pharma applications

BIO-EUROPE SPRING

The 13th Annual International Partnering Conference BIO-EUROPE SPRING will be held on March 25–27, 2019 in Vienna, Austria. The following

Continue reading

Recent Posts

  • Recent books on cyclodextrins
  • β-cyclodextrin complexes with propolis and royal jelly components
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (206)
  • CD derivatives (257)
  • Cosmetics and toilettry (21)
  • Drug delivery (437)
  • E-ducation (54)
  • Environmental (77)
  • Events (160)
  • Food (124)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (15)
  • Non-pharma applications (215)
  • Other industrial use (59)
  • Pharma applications (703)
  • Supramolecular systems (25)
  • Uncategorized (43)

Top Posts

  • Recent books on cyclodextrins
  • Lanosterol eye drops for cataract treatment
  • 7th European Cyclodextrin Conference
  • β-cyclodextrin complexes with propolis and royal jelly components
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Website of EuroCD Conference is open
  • How air fresheners work?
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Methyl BCD alters cell envelop studied by AFM
  • International Symposium of Drug Delivery Systems (SDDS-2022)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 524 other subscribers
 

Loading Comments...